SCHEMBL328409

SCHEMBL328409

CNCCN(CC(N)=O)S(=O)(=O)c1cc(F)c(Oc2ccc(F)cc2)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 2/20 0.38
MMP7 P09237 2/20 0.38
MMP8 P22894 2/20 0.38
MMP12 P39900 2/20 0.38
MMP13 P45452 2/20 0.38
SLC9A3 P48764 6/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 2/20 0.35
TAS2R14 Q9NYV8 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
RAB9A P51151 1/20 0.34
CACNA1H O95180 1/20 0.34
CACNA1B Q00975 1/20 0.34
MEP1B Q16820 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6863736 0.89 MMP1 (0.53) MMP1MMP7MMP8MMP12MMP13
SCHEMBL6852278 0.87 CACNA1H (0.40) MMP1MMP7MMP8MMP12MMP13
SCHEMBL328416 0.81 SMN1; SMN2 (0.35) MMP1MMP7MMP8MMP12MMP13
SCHEMBL328408 0.81 PDK2 (0.35) MMP1MMP7MMP8MMP12MMP13
SCHEMBL6852280 0.78 BDKRB1 (0.40) SLC9A3MEN1KMT2AALDH1A1
SCHEMBL328403 0.77 MEN1 (0.40) MEN1KMT2ALMNAALDH1A1SMN1; SMN2
SCHEMBL328414 0.77 DAGLA (0.37) KMT2AALDH1A1SMN1; SMN2
SCHEMBL6850664 0.76 DAGLA (0.43) MMP1MMP8MMP13SLC9A3ALDH1A1
SCHEMBL328548 0.76 DAGLA (0.37) SLC9A3KMT2AALDH1A1SMN1; SMN2
SCHEMBL328661 0.76 KMT2A (0.38) KMT2AALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428509-A1 Human adam-10 inhibitors Symphony Evolution, Inc. (US) 2012-03-14 EP disclosed
WO-2011011181-A1 PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AMICUS THERAPEUTICS, INC. (US) 2011-01-27 WO disclosed